Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Patrick Reynolds

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
British Journal of Pharmacology|July 22, 2014
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastomaPoonam Sonawane, Hwang Eui Cho, Ashujit Tagde, et al.
Anti-Cancer Drugs|December 16, 2020
The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide + irinotecan against models of high-risk neuroblastomaAshly Hindle, Balakrishna Koneru, Monish Ram Makena, et al.
Frontiers in Oncology|September 3, 2024
Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assayTrevor A Burrow, Balakrishna Koneru, Shawn J Macha, et al.
Molecular Cancer Therapeutics|August 18, 2016
Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma XenograftsNancy E Chen, N Vanessa Maldonado, Vazgen Khankaldyyan, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cellsHyung-Gyoo Kang, Jasmine M Jenabi, Xian Fang Liu, et al.
Pediatric Blood & Cancer|January 12, 2010
A feasibility trial of a video intervention to improve informed consent for parents of children with leukemiaRebecca A Hazen, Michelle Eder, Dennis Drotar, et al.
Journal of Neuro-Oncology|May 6, 2014
Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrationsAhsan S Farooqi, Rebecca A Dagg, L Mi Rim Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709), Judith G Villablanca, Mark D Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activityTheresa M Harned, Ondrej Kalous, Alexander Neuwelt, et al.
Cancer Research|October 3, 2007
The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferationHongjun Peng, Yasuyoshi Sohara, Rex A Moats, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
British Journal of Pharmacology|July 22, 2014
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastomaPoonam Sonawane, Hwang Eui Cho, Ashujit Tagde, et al.
Anti-Cancer Drugs|December 16, 2020
The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide + irinotecan against models of high-risk neuroblastomaAshly Hindle, Balakrishna Koneru, Monish Ram Makena, et al.
Frontiers in Oncology|September 3, 2024
Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assayTrevor A Burrow, Balakrishna Koneru, Shawn J Macha, et al.
Molecular Cancer Therapeutics|August 18, 2016
Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma XenograftsNancy E Chen, N Vanessa Maldonado, Vazgen Khankaldyyan, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cellsHyung-Gyoo Kang, Jasmine M Jenabi, Xian Fang Liu, et al.
Pediatric Blood & Cancer|January 12, 2010
A feasibility trial of a video intervention to improve informed consent for parents of children with leukemiaRebecca A Hazen, Michelle Eder, Dennis Drotar, et al.
Journal of Neuro-Oncology|May 6, 2014
Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrationsAhsan S Farooqi, Rebecca A Dagg, L Mi Rim Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709), Judith G Villablanca, Mark D Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activityTheresa M Harned, Ondrej Kalous, Alexander Neuwelt, et al.
Cancer Research|October 3, 2007
The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferationHongjun Peng, Yasuyoshi Sohara, Rex A Moats, et al.
Pageof 19